HNRNPA2B1 and neoplasm: miR-184-3p was shown to be selectively packaged into exosomes by heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2B1) and to suppress M2 macrophage polarisation, thereby reducing pro-tumour immune responses and metastatic potential.